Figures computed from official regulatory filings — .
Analysttarget 7 USD (+56%)
Ownershipinsiders 21.39% · institutions 45.14% · short 3.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ORAMED PHARMACEUTICALS INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
48 buys30 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Gabay Avraham | Sell | $90.2K | SEC |
| Hexter Joshua | Sell | $135.3K | SEC |
| Kidron Miriam | Award | n/a (No price was disclosed in the filing) | SEC |
| KIDRON NADAVtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kidron Miriam | Award | n/a (No price was disclosed in the filing) | SEC |
| Hexter Joshua | Award | n/a (No price was disclosed in the filing) | SEC |
| Gabay Avraham | Award | n/a (No price was disclosed in the filing) | SEC |
| KIDRON NADAVtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Hexter Joshua | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| KIDRON NADAVtrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Hexter Joshua | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Hexter Joshua | Award | n/a (No price was disclosed in the filing) | SEC |
| KIDRON NADAVtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kidron Miriam | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kidron Miriam | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| KIDRON NADAVtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Hexter Joshua | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kidron Miriam | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kidron Miriam | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| KIDRON NADAVtrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| KIDRON NADAVtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kidron Miriam | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| KIDRON NADAVtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kidron Miriam | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gabay Avraham | Sell | $330.7K | SEC |